Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Black men are "put in disproportionate danger of dying" from prostate cancer due to health inequities and outdated NHS guidelines, a leading charity has said. Prostate Cancer UK says that black ...

Discover a study where results from the 2,129 participants revealed that Stockholm3 demonstrated non-inferior sensitivity ...

Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously ... Dec. 19, 2024 — There are several ...

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the approach, developed at Heriot Watt University in Edinburgh, could lead ...

BBC Outnumbered star Hugh Dennis is sending out a message over prostate cancer. It comes after a Christmas special of the show revealed that Pete, the character he plays, has the condition.

Epidemiologic evidence supports the role of PSA screening in the stage and grade migration of prostate cancer, but to date the evidence for its role in changing mortality patterns is more equivocal.

If your biopsy confirms the presence of prostate cancer, a doctor will examine your cancer cells in a lab to determine how much they differ from healthy cells. A higher grade indicates a more ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...

Prostate cancer treatments lead to higher long-term complication rates, emphasizing the need for informed decision-making regarding treatment options and side effects. Prostatectomy patients ...

While the results are promising, researchers did not find any differences in other cancer growth markers, such as Gleason grade, which are commonly used to track prostate cancer progression.